Pyrazolopyridines
![eMolecules 2304634-03-3 | {2-methyl-2H-pyrazolo[3,4-b]pyridin-5-yl}boronic acid | Pharmablock | MFCD20926164 | 176.970 | C7H8BN3O2 | 97.000 | Cn1cc2cc(cnc2n1)B(O)O | 50mg | 551130555](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000493126.jpg-250.jpg)
eMolecules 2304634-03-3 | {2-methyl-2H-pyrazolo[3,4-b]pyridin-5-yl}boronic acid | Pharmablock | MFCD20926164 | 176.970 | C7H8BN3O2 | 97.000 | Cn1cc2cc(cnc2n1)B(O)O | 50mg | 551130555
{2-methyl-2H-pyrazolo[3,4-b]pyridin-5-yl}boronic acid | Pharmablock | 2304634-03-3 | MFCD20926164 | 176.970 | C7H8BN3O2 | 97.000 | Cn1cc2cc(cnc2n1)B(O)O | 50mg | 551130555
Medchemexpress LLC 5,5'-Dicarboxy-2,2'-bipyridine | 1802-30-8 | 244.20 | 1 G
5,5'-Dicarboxy-2,2'-bipyridine is a niacin derivative with potential applications in the research of conditions such as hypercholesterolemia, hyperlipidemia, and cardiovascular disease. This chemical compound is provided as an off-white to gray solid and is characterized by its molecular formula C₁₂H₈N₂O₄ and a molecular weight of 244.20.
- High purity of 99.76% (HPLC)
- Promising for research of hypercholesterolemia
- Promising for research of hyperlipidemia
- Promising for research of cardiovascular disease
- Consistent with structure by ¹H NMR spectroscopy
- Soluble in DMSO: 2 mg/mL
![eMolecules 1264193-11-4 | 6-Bromopyrazolo[1?5-a]pyridine | AA Blocks LLC | MFCD18633056 | 197.035 | C7H5BrN2 | 0.000 | Brc1ccc2ccnn2c1 | 100mg | 784388683](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000126091.jpg-250.jpg)
eMolecules 1264193-11-4 | 6-Bromopyrazolo[1?5-a]pyridine | AA Blocks LLC | MFCD18633056 | 197.035 | C7H5BrN2 | 0.000 | Brc1ccc2ccnn2c1 | 100mg | 784388683
6-Bromopyrazolo[1?5-a]pyridine | AA Blocks LLC | 1264193-11-4 | MFCD18633056 | 197.035 | C7H5BrN2 | 0.000 | Brc1ccc2ccnn2c1 | 100mg | 784388683
![Medchemexpress LLC 2-[3-carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid | 1239233-87-4 | MFCD29050077 | 98.8% | 335.37 | C16H17NO5S | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000263028.png-250.jpg)
Medchemexpress LLC 2-[3-carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid | 1239233-87-4 | MFCD29050077 | 98.8% | 335.37 | C16H17NO5S | 5 MG
Febuxostat dicarboxylic acid impurity is an analytical reference impurity derived from the xanthine oxidase inhibitor febuxostat, provided for research and quality-control applications. It is intended for use in analytical characterization, method development, and impurity profiling in pharmaceutical analysis.
- Analytical reference impurity for febuxostat.
- High purity for reliable analytical results.
- Suitable for method development and impurity profiling.
- Provided with supporting analytical documentation such as COA.
- Supplied in small, research-grade quantities for laboratory use.
Medchemexpress LLC 5-Bromo-1H-pyrazolo[3,4-b]pyridine | 875781-17-2 | 99.8% | C6H4BrN3 | 10 G
5-Bromo-1H-pyrazolo[3,4-b]pyridine is a drug intermediate used for the synthesis of sulfonamide derivatives. It is for research use only.
- Used for synthesis of sulfonamide derivatives
- For research use only
- Drug intermediate
- Anti-bacterial activity
- Antioxidant
![eMolecules 1378592-49-4 | 6-Fluoro-1H-pyrazolo[4,3-b]pyridine | Chemcia | MFCD16659574 | 137.117 | C6H4FN3 | 95.000 | Fc1cnc2cn[nH]c2c1 | 1g | 487934934](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000162099.jpg-250.jpg)
eMolecules 1378592-49-4 | 6-Fluoro-1H-pyrazolo[4,3-b]pyridine | Chemcia | MFCD16659574 | 137.117 | C6H4FN3 | 95.000 | Fc1cnc2cn[nH]c2c1 | 1g | 487934934
6-Fluoro-1H-pyrazolo[4,3-b]pyridine | Chemcia | 1378592-49-4 | MFCD16659574 | 137.117 | C6H4FN3 | 95.000 | Fc1cnc2cn[nH]c2c1 | 1g | 487934934
eMolecules 1264193-11-4 | 6-Bromopyrazolo[1?5-a]pyridine | AA Blocks LLC | MFCD18633056 | 197.035 | C7H5BrN2 | 0.000 | Brc1ccc2ccnn2c1 | 5g | 410147772
6-Bromopyrazolo[1?5-a]pyridine | AA Blocks LLC | 1264193-11-4 | MFCD18633056 | 197.035 | C7H5BrN2 | 0.000 | Brc1ccc2ccnn2c1 | 5g | 410147772
eMolecules 1264193-11-4 | 6-Bromopyrazolo[1,5-a]pyridine | Ambeed | MFCD18633056 | 197.035 | C7H5BrN2 | 97.000 | Brc1ccc2ccnn2c1 | 5g | 572823883
6-Bromopyrazolo[1,5-a]pyridine | Ambeed | 1264193-11-4 | MFCD18633056 | 197.035 | C7H5BrN2 | 97.000 | Brc1ccc2ccnn2c1 | 5g | 572823883
Medchemexpress LLC 5,5'-Dicarboxy-2,2'-bipyridine | 1802-30-8 | 244.20 | 10 MG
5,5'-Dicarboxy-2,2'-bipyridine is a niacin derivative with potential applications in hypercholesterolemia, hyperlipidemia, and cardiovascular disease research.
- Promising for research of hypercholesterolemia
- Promising for research of hyperlipidemia
- Promising for research of cardiovascular disease
eMolecules 42754-96-1 | 4,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine | Accela ChemBio (ASD) | MFCD09835493 | 189.000 | C5H2Cl2N4 | 97.000 | Clc1nc(Cl)c2cn[nH]c2n1 | 1g | 503196512
4,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine | Accela ChemBio (ASD) | 42754-96-1 | MFCD09835493 | 189.000 | C5H2Cl2N4 | 97.000 | Clc1nc(Cl)c2cn[nH]c2n1 | 1g | 503196512
![eMolecules 1264193-11-4 | 6-BROMOPYRAZOLO[1,5-A]PYRIDINE | AstaTech | MFCD18633056 | 197.035 | C7H5BrN2 | 95.000 | Brc1ccc2ccnn2c1 | 5g | 385236908](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000216978.jpg-250.jpg)
eMolecules 1264193-11-4 | 6-BROMOPYRAZOLO[1,5-A]PYRIDINE | AstaTech | MFCD18633056 | 197.035 | C7H5BrN2 | 95.000 | Brc1ccc2ccnn2c1 | 5g | 385236908
6-BROMOPYRAZOLO[1,5-A]PYRIDINE | AstaTech | 1264193-11-4 | MFCD18633056 | 197.035 | C7H5BrN2 | 95.000 | Brc1ccc2ccnn2c1 | 5g | 385236908
Medchemexpress LLC 5,5'-Dicarboxy-2,2'-bipyridine | 1802-30-8 | 244.20 | 5 G
5,5'-Dicarboxy-2,2'-bipyridine is an off-white to gray solid and a niacin derivative that shows promise in research related to hypercholesterolemia, hyperlipidemia, and cardiovascular disease.
- High purity (99.8% by HPLC)
- Stable under recommended storage conditions
- Recommended storage at 4°C, protected from light and under nitrogen
- Soluble in DMSO (2 mg/mL)
- Suitable for research on hypercholesterolemia, hyperlipidemia, and cardiovascular disease
